Annette Little

Annette Little has a diverse work experience in the field of life sciences. Annette is currently serving as the Head of CLE and Screening Service Operations at Revvity since May 2023. Prior to that, they worked at Horizon Discovery, where they held multiple roles such as Head of CLE and Screening Service Operations, Head of Assays & Screening, Group Leader, and Team Leader from 2011 to 2023. Before joining Horizon Discovery, they worked at Babraham Bioscience Technologies Ltd as a Postdoc from 2007 to 2011, focusing on tumor cell responses to FGFR and MAPK pathway inhibitors. Annette also worked as a PhD CASE student at the University of Leeds / AstraZeneca from 2003 to 2007.

Annette Little obtained a Bachelor of Science (BSc) in Biochemistry with Medical Biochemistry from the University of Leeds in 2003. From 2003 to 2007, they pursued a Doctor of Philosophy (Ph.D.) in Cell Biology at the same university. Before their university education, they attended Chelmsford County High School from 1992 to 1999.